Results 171 to 180 of about 154,933 (274)

Risk-based guidance for choosing fecal immunochemical test or colonoscopy in colorectal cancer screening: a modeling study. [PDF]

Am J Epidemiol
van Duuren LA, Bulliard JL, Harlass M, Plys E, Corley DA, Froehlich F, Selby K, Lansdorp-Vogelaar I.   +7 more
europepmc   +1 more source

The Allium cepa Derived Compound Propyl Propane Thiosulfonate (PTSO) Improves Tumorigenesis Due to Its Immunomodulatory Effect: A Preclinical Study

Phytotherapy Research, EarlyView.
In vitro and in vivo effects of PTSO in colorectal cancer preclinical models, highlighting antiproliferative, pro‐apoptotic, barrier‐enhancing, antitumor, prebiotic and immunomodulatory properties. Created using BioRender. ABSTRACT Allium‐derived organosulfur compounds offer significant health benefits.
María Jesús Rodríguez‐Sojo, Laura Hidalgo‐García, Jose Alberto Molina‐Tijeras, Laura López‐Escanez, Luckman Gbati, Teresa Vezza, Patricia Diez‐Echave, Antonio Jesús Ruiz‐Malagón, Jorge García‐García, Federico García, Alberto Baños, Lidia Gil‐Martínez, Rocío López‐Posadas, Markus F. Neurath, Julio Gálvez, María Elena Rodríguez‐Cabezas, Alba Rodríguez‐Nogales   +16 more
wiley   +1 more source

Artificial Intelligence-Driven Colonoscopy: A Systematic Review and Network Meta-Analysis on System Performance for Colorectal Neoplasia Detection. [PDF]

JGH Open
Eman FNU, Gyaneshwari FNU, Kumari R, Jabeen A, Kumari K, Mansha FNU, Sattar S, Zehra F, Hotwani S, Kakar MT, Riaz H.   +10 more
europepmc   +1 more source

Farnesoid X receptor prevents hyperuricemia via activating ATP‐binding cassette subfamily G member 2

Rheumatology &Autoimmunity, EarlyView.
Farnesoid X receptor (FXR) activation reduces serum uric acid levels by upregulating the intestinal urate transporter ATP‐binding cassette subfamily G member 2 (ABCG2). These findings uncover a novel metabolic pathway for urate excretion and suggest that FXR agonists (e.g., obeticholic acid), represent a promising therapeutic strategy for the treatment
Rui Li, Guo Tang, Ye Yu, Guang‐Liang Chen, Liangjing Lu, Juan Wang   +5 more
wiley   +1 more source

Positive predictive value of symptoms for early-onset colorectal cancer. [PDF]

Cancer Epidemiol Biomarkers Prev
Chubak J, Ichikawa L, Ziebell RA, Udaltsova N, Corley DA, Ghai NR, Lee JK, Halm EA, Skinner CS, Quesenberry C, Schottinger JE, Levin TR.   +11 more
europepmc   +1 more source

Imaging of Abdominal Complications in Children With Acute Lymphoblastic Leukaemia

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and remains one of the most common causes of cancer‐related death in children and adolescents. Five‐year overall survival rates now exceed 90% with current multidrug chemotherapeutic regimens. This improvement, coupled with the toxicity of chemotherapy, has led to the
Luke R. Holmes, Rishi S. Kotecha, Derek J. Roebuck   +2 more
wiley   +1 more source

Implementing a successful patient navigation program for follow-up colonoscopy: Lessons from the PRECISE study. [PDF]

PLoS One
Thompson JH, Schneider JL, Rivelli JS, Gautom P, Gibbs J, Yadav N, Jimenez R, Coronado GD.   +7 more
europepmc   +1 more source

Timely Delivery of Care and the Optimal Care Pathway for People With Colorectal Cancer: A Scoping Review

Asia-Pacific Journal of Clinical Oncology, EarlyView.
The “Optimal care pathway for people with colorectal cancer” is a framework designed to support clinicians delivering high‐quality, timely care to patients; however, it is unknown whether this has affected outcomes across Australia. The variable results in this review suggest that this guideline is yet to be integrated nationally. ABSTRACT The “Optimal
Elliott Benjamin Fox, Dennis Perez Castillo, Nathan Bain, Amy Brown   +3 more
wiley   +1 more source

1 versus 2 L PEG/Asc for bowel preparation in patients with hematochezia: a multicenter, prospective, randomized, non-inferiority study. [PDF]

Ther Adv Gastroenterol
Kim SY, Lee SH, Lee J, Kim H, Park HJ, Kim HS.   +5 more
europepmc   +1 more source

Are Social Media Platforms an Effective Forum for Engaging Early‐Onset Cancer Survivors? Insights From X (Formerly Twitter)

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This study presents a novel approach to understanding whether social media can be used to effectively communicate with cancer survivors. Posts generated by early‐onset cancer survivors were scarce, while clinician‐ and researcher‐produced content dominated.
Abby Dawson, Savio George Barreto
wiley   +1 more source